What is the current GABA market size?

The GABA market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the GABA market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the GABA market?

Key drivers include growing awareness of mental health and rising demand for natural supplements.

What challenges does the GABA market face?

Challenges include regulatory hurdles and competition from synthetic alternatives.

Which regions lead the GABA market?

North America and Europe are regional leaders, driven by high demand for dietary supplements.

Who are the top companies in the GABA market?

Top companies include NOW Foods, Jarrow Formulas, and Source Naturals, known for their high-quality products.

What future opportunities exist in the GABA market?

Future opportunities include expanding into new applications, such as cosmetics and pharmaceuticals.

How does technology impact the GABA market?

Technology advancements improve manufacturing efficiency and enable the development of new products.

What is the current regulatory landscape for the GABA market?

The regulatory landscape is evolving, with increasing scrutiny on product labeling and claims.

What is the future outlook for the GABA market?

The future outlook is positive, driven by growing demand for natural and holistic health solutions.

GABA (γ-aminobutyric acid) Market: Opportunity by 2034 | In-Depth Report

GABA (γ-aminobutyric acid) by Application (Food and Pharmaceutical, Animal Feed, Plant Growth Promoter, Others), by Types (Microbial Fermentation (Food Grade), Microbial Fermentation (Feed Grade), Chemical Synthesis), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 172

Forecast Period: 2026 - 2033

Market Size: $86 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 172

Forecast Period: 2026 - 2033

Market Size: $86 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

GABA (γ-aminobutyric acid) Market Size | CAGR 6.2% Forecast 2033

GABA (γ-aminobutyric acid) Market: Opportunity by 2034 | In-Depth Report

🏭 Chemicals & Materials🌍 Global

Pages: 172

Forecast Period: 2026 - 2033

Market Size: $86 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 172

Forecast Period: 2026 - 2033

Market Size: $86 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

GABA (γ-aminobutyric acid) Market Overview

The GABA (γ-aminobutyric acid) market refers to the global industry involved in the production and distribution of GABA, a naturally occurring amino acid with various applications. As the GABA market size is estimated to be around $1.36 billion, its growth outlook and market forecast are of significant interest to industry stakeholders. The GABA market forecast indicates a positive growth trajectory, driven by increasing demand for natural and organic products, with a compound annual growth rate (CAGR) of 5.5% during the forecast period. The scope of the GABA market encompasses various segments, including pharmaceuticals, food and beverages, and dietary supplements, with the largest segment being the pharmaceutical industry.

Loading chart…

The GABA market is shaped by key forces such as technology shifts towards more efficient production methods, regulations supporting the use of natural ingredients, and consumer behavior driving demand for health and wellness products. The largest region in the GABA market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing demand for dietary supplements and functional foods. As the GABA market continues to expand, industry players must navigate these trends and forces to capitalize on emerging opportunities and stay competitive in the global market.

Report Overview

Report Attribute	Details
Market size value in 2025	86.00 million
Revenue forecast in 2033	149.99 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pharma Foods International; Kyowa Hakko Bio Co., Ltd.; Sekisui Chemical Co., Ltd.; Zhejiang YiWan Biolabs; Shanghai Richen; Guangdong Luckerkong Biotech; Tianjin Shijitianlong Biotech; Ningxiang Jiayuan Biology Technology; Zhejiang Tianrui Chemical; Taizhou Xinyou Pharmaceutical & Chemical; Bloomage Freda Biopharm
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The GABA (γ-aminobutyric acid) market is poised for significant growth, driven by increasing demand for neurological disorder treatments and rising awareness about the benefits of GABA supplements. The GABA (γ-aminobutyric acid) market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Growing prevalence of anxiety disorders and insomnia, leading to increased adoption of GABA supplements as a natural remedy

Advances in fermentation technology, enabling the production of high-quality GABA at a lower cost, thereby driving the growth of the GABA (γ-aminobutyric acid) market

Restraints2 items

Stringent regulatory requirements for GABA-based products, particularly in the pharmaceutical sector, may hinder market growth

Limited awareness about the benefits of GABA supplements in certain regions, affecting the overall GABA (γ-aminobutyric acid) market size

Opportunities2 items

Increasing demand for natural and organic products, creating opportunities for GABA manufacturers to develop innovative, high-quality supplements

Growing interest in mental health and wellness, driving the adoption of GABA-based products and contributing to a positive growth forecast for the GABA (γ-aminobutyric acid) market

Challenges2 items

Intense competition in the GABA market, with numerous players offering similar products, which may lead to pricing pressures and reduced profit margins

Fluctuations in raw material prices, affecting the production costs of GABA and potentially impacting the overall GABA (γ-aminobutyric acid) market size

Market Segmentation

Loading chart…

The GABA (γ-aminobutyric acid) market can be segmented based on Application, which includes subtypes such as pharmaceuticals, food and beverages, and nutraceuticals. This segmentation contributes to the overall GABA market size by highlighting the various industries that utilize GABA as an ingredient. Understanding the GABA segmentation by application is crucial for companies to identify potential opportunities and challenges in the market.

Another way to segment the GABA market is by Types, which includes subtypes such as natural GABA and synthetic GABA. This segmentation is essential in understanding the different production methods and sources of GABA, which can impact the quality and pricing of the final product. The market taxonomy of GABA by types provides insights into the supply chain and manufacturing processes, enabling companies to make informed decisions about their product offerings and target markets.

GABA (γ-aminobutyric acid) Segmentation Breakdown9 items

Application

Food and Pharmaceutical

Animal Feed

Plant Growth Promoter

Others

Types

Microbial Fermentation (Food Grade)

Microbial Fermentation (Feed Grade)

Chemical Synthesis

Regional Insights

Loading chart…

The GABA (γ-aminobutyric acid) market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and Latin America being the fastest-growing region. Key drivers for the Asia Pacific region include increasing adoption of GABA-based products, favorable policies supporting the growth of the nutraceutical industry, and significant investments in research and development.

In North America, key drivers include a mature ecosystem with established players, a high level of infrastructure supporting the production and distribution of GABA-based products, and a growing demographics of health-conscious consumers. Europe is driven by stringent regulations ensuring high-quality products, a strong pharmaceutical industry, and increasing awareness of the benefits of GABA supplements.

The regional forecast indicates that Latin America will experience rapid growth due to increasing demand for natural and organic products, improving economic conditions, and expanding distribution channels. The Middle East & Africa region is expected to grow steadily, driven by a rising middle class, growing interest in health and wellness, and increasing availability of GABA-based products.

Competitive Landscape

The GABA (γ-aminobutyric acid) market exhibits a moderately consolidated structure, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The GABA (γ-aminobutyric acid) competitive landscape is characterized by key competitive levers, including certifications and regulatory approvals. Global players tend to dominate the market, but local companies are also present, often focusing on regional markets and niche applications.

Companies in the GABA market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must develop unique value propositions, leveraging technology, service models, or channel strength. Some companies focus on premium pricing, while others prioritize cost advantages or customization.

Pharma Foods International: regional expansion

Kyowa Hakko Bio Co., Ltd.: vertical integration

Sekisui Chemical Co., Ltd.: innovation pipeline

Zhejiang YiWan Biolabs: local manufacturing

Shanghai Richen: OEM tie-ups

Guangdong Luckerkong Biotech: premium pricing

Key GABA (γ-aminobutyric acid) Companies11 items

Pharma Foods International

Kyowa Hakko Bio Co., Ltd.

Sekisui Chemical Co., Ltd.

Zhejiang YiWan Biolabs

Shanghai Richen

Guangdong Luckerkong Biotech

Tianjin Shijitianlong Biotech

Ningxiang Jiayuan Biology Technology

Zhejiang Tianrui Chemical

Taizhou Xinyou Pharmaceutical & Chemical

Bloomage Freda Biopharm

Market Ecosystem

The GABA (γ-aminobutyric acid) ecosystem encompasses a complex network of participants, from upstream raw material suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, midstream, and downstream, with value being created and captured at each stage. The GABA ecosystem involves various technology providers, suppliers, integrators, channels, and end users, all of which contribute to the creation and delivery of GABA products.

Raw material suppliers — providing base chemicals

OEMs / manufacturers — producing GABA products

Technology providers — developing production technologies

System integrators / EPCs — integrating GABA into final products

Distributors / channel partners — delivering GABA products to market

Regulators/standards bodies — setting quality and safety standards

End users / buyers — consuming GABA products

In the GABA ecosystem, control points are primarily held by regulators and standards bodies, as well as by large OEMs and manufacturers. Dependency risks arise from input constraints, such as the availability of raw materials, and from standards and approvals required for GABA products. Switching costs are relatively high due to the specialized nature of GABA production technologies and the need for interoperability with downstream systems. The GABA ecosystem differs by region, with varying regulatory requirements and market demand influencing the structure and participants in each region, highlighting the need for a detailed value chain analysis to understand these dynamics.

Recent Industry Insights

The GABA (γ-aminobutyric acid) industry trends have witnessed significant developments over the last 12-18 months. Notably, there has been a surge in partnerships between key players, focusing on enhancing production capacities and expanding distribution networks. Additionally, the industry has seen a few strategic mergers & acquisitions, aimed at strengthening market positions and diversifying product portfolios.

Recent product/technology launches have also been instrumental in driving growth, with companies introducing innovative GABA-based products for various applications. Furthermore, shifts in consumer preferences towards natural and holistic wellness solutions have contributed to the increasing demand for GABA products. The GABA industry is poised for continued growth, driven by evolving GABA (γ-aminobutyric acid) industry trends and ongoing investments in research and development.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the GABA (γ-aminobutyric acid) market outlook. The market attractiveness is moderate, driven by increasing demand for natural ingredients in the pharmaceutical and food industries. Competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, with growing awareness of the benefits of GABA expected to drive demand.

The innovation landscape is characterized by ongoing research into new applications and delivery methods. The demand-supply balance is currently stable, but may shift in response to changes in regulatory environments or consumer preferences. Key risk factors include fluctuations in raw material prices and potential regulatory challenges. Overall, the GABA market is expected to experience steady growth, driven by increasing demand for natural and effective ingredients.

11 items

1. Executive Summary

2. GABA (γ-aminobutyric acid) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global GABA (γ-aminobutyric acid) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global GABA (γ-aminobutyric acid) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Food and Pharmaceutical

6.1.2. Animal Feed

6.1.3. Plant Growth Promoter

6.1.4. Others

6.2. Global GABA (γ-aminobutyric acid) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Microbial Fermentation (Food Grade)

6.2.2. Microbial Fermentation (Feed Grade)

6.2.3. Chemical Synthesis

6.3. Global GABA (γ-aminobutyric acid) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global GABA (γ-aminobutyric acid) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global GABA (γ-aminobutyric acid) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global GABA (γ-aminobutyric acid) Market Competition by Key Manufacturers

8.1. Global GABA (γ-aminobutyric acid) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global GABA (γ-aminobutyric acid): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Pharma Foods International

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Kyowa Hakko Bio Co., Ltd.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Sekisui Chemical Co., Ltd.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Zhejiang YiWan Biolabs

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Shanghai Richen

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Guangdong Luckerkong Biotech

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Tianjin Shijitianlong Biotech

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Ningxiang Jiayuan Biology Technology

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Zhejiang Tianrui Chemical

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Taizhou Xinyou Pharmaceutical & Chemical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Bloomage Freda Biopharm

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global GABA (γ-aminobutyric acid) Market

Figure 4: Global GABA (γ-aminobutyric acid) Market: Drivers

Figure 5: Global GABA (γ-aminobutyric acid) Market: Challenges

Figure 6: Global GABA (γ-aminobutyric acid) Market: Trends

Figure 7: Global GABA (γ-aminobutyric acid) Market: Opportunity

Figure 8: Global GABA (γ-aminobutyric acid) Market: Restraint

Figure 9: Global GABA (γ-aminobutyric acid) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global GABA (γ-aminobutyric acid) Market Value (USD Million) By Region

Figure 15: Global GABA (γ-aminobutyric acid) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global GABA (γ-aminobutyric acid) Market Value (USD Million) By Region

Figure 23: Global GABA (γ-aminobutyric acid) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global GABA (γ-aminobutyric acid) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global GABA (γ-aminobutyric acid) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global GABA (γ-aminobutyric acid) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global GABA (γ-aminobutyric acid) Market Value (USD Million) By Region

Table 10: Global GABA (γ-aminobutyric acid) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global GABA (γ-aminobutyric acid) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global GABA (γ-aminobutyric acid) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global GABA (γ-aminobutyric acid) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Pharma Foods International Basic Information And Sales Area

Table 31: Pharma Foods International. Products Portfolio

Table 32: Kyowa Hakko Bio Co., Ltd. Basic Information And Sales Area

Table 33: Kyowa Hakko Bio Co., Ltd.. Products Portfolio

Table 34: Sekisui Chemical Co., Ltd. Basic Information And Sales Area

Table 35: Sekisui Chemical Co., Ltd.. Products Portfolio

Table 36: Zhejiang YiWan Biolabs Basic Information And Sales Area

Table 37: Zhejiang YiWan Biolabs. Products Portfolio

Table 38: Shanghai Richen Basic Information And Sales Area

Table 39: Shanghai Richen. Products Portfolio

Table 40: Guangdong Luckerkong Biotech Basic Information And Sales Area

Table 41: Guangdong Luckerkong Biotech. Products Portfolio

Table 42: Tianjin Shijitianlong Biotech Basic Information And Sales Area

Table 43: Tianjin Shijitianlong Biotech. Products Portfolio

Table 44: Ningxiang Jiayuan Biology Technology Basic Information And Sales Area

Table 45: Ningxiang Jiayuan Biology Technology. Products Portfolio

Table 46: Zhejiang Tianrui Chemical Basic Information And Sales Area

Table 47: Zhejiang Tianrui Chemical. Products Portfolio

Table 48: Taizhou Xinyou Pharmaceutical & Chemical Basic Information And Sales Area

Table 49: Taizhou Xinyou Pharmaceutical & Chemical. Products Portfolio

Table 50: Bloomage Freda Biopharm Basic Information And Sales Area

Table 51: Bloomage Freda Biopharm. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global GABA (γ-aminobutyric acid) Market Value (USD Million) By Region

Table 57: Global GABA (γ-aminobutyric acid) Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

GABA (γ-aminobutyric acid) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	86.00 million
Revenue forecast in 2033	149.99 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pharma Foods International; Kyowa Hakko Bio Co., Ltd.; Sekisui Chemical Co., Ltd.; Zhejiang YiWan Biolabs; Shanghai Richen; Guangdong Luckerkong Biotech; Tianjin Shijitianlong Biotech; Ningxiang Jiayuan Biology Technology; Zhejiang Tianrui Chemical; Taizhou Xinyou Pharmaceutical & Chemical; Bloomage Freda Biopharm
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options